Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ARFXF - PROMIS NEUROSCIENCES INC
Market Cap 44.04M P/E - EPS this Y - Ern Qtrly Grth -
Income -11.78M Forward P/E - EPS next Y - 50D Avg Chg -98.00%
Sales 10.38k PEG - EPS past 5Y - 200D Avg Chg -98.00%
Dividend N/A Price/Book 9.27 EPS next 5Y - 52W High Chg -99.00%
Recommedations 2.00 Quick Ratio 18.34 Shares Outstanding 431.73M 52W Low Chg 7.00%
Insider Own 5.01% ROA -55.17% Shares Float 409.47M Beta 1.04
Inst Own 0.02% ROE -364.81% Shares Shorted/Prior -/- Price 0.10
Gross Margin - Profit Margin - Avg. Volume 3,129 Target Price -
Oper. Margin -101,421.71% Earnings Date May 12 Volume 685,017 Change -0.58%
Healthcare | Biotechnology | Canada
About PROMIS NEUROSCIENCES INC

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

ARFXF Chatroom

User Image cctranscripts Posted - 01/05/24

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12847379 $ARFXF

User Image cctranscripts Posted - 01/05/24

Promis Neurosciences Inc just filed a prospectus, suggesting it plans to soon issue some securi https://www.conferencecalltranscripts.org/summary/?id=12847367 $ARFXF

User Image cctranscripts Posted - 01/05/24

Promis Neurosciences Inc's Chief Executive Officer was just granted 200,000 options https://www.conferencecalltranscripts.org/summary/?id=12846780 $ARFXF

User Image cctranscripts Posted - 01/03/24

Promis Neurosciences, Inc. Announces Leadership Transition Appoints Neil Warma, https://www.conferencecalltranscripts.org/summary/?id=12836942 $ARFXF

User Image cctranscripts Posted - 3 months ago

Jeremy M. Sclar just provided an update on share ownership of Promis Neurosciences Inc https://www.conferencecalltranscripts.org/summary/?id=12834216 $ARFXF

User Image cctranscripts Posted - 3 months ago

Major owner of Promis Neurosciences Inc was just granted 326,217 ownership of the company. https://www.conferencecalltranscripts.org/summary/?id=12834205 $ARFXF

User Image cctranscripts Posted - 12/27/23

Title just provided an update on share ownership of Promis Neurosciences Inc https://www.conferencecalltranscripts.org/summary/?id=12822680 $ARFXF

User Image cctranscripts Posted - 12/27/23

Major owner of Promis Neurosciences Inc just declared owning 1,110,513 shares of Promis Neurosc https://www.conferencecalltranscripts.org/summary/?id=12822678 $ARFXF

User Image cctranscripts Posted - 12/27/23

Major owner of Promis Neurosciences Inc just declared owning 1,158,846 shares of Promis Neurosc https://www.conferencecalltranscripts.org/summary/?id=12822668 $ARFXF

User Image cctranscripts Posted - 12/08/23

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12777849 $ARFXF

User Image cctranscripts Posted - 11/20/23

Promis Neurosciences Doses First Subjects In Phase 1A Clinical Trial Of Pmn310 To Treat Alzheim https://www.conferencecalltranscripts.org/summary/?id=12722886 $ARFXF

User Image cctranscripts Posted - 10/30/23

Promis Neurosciences Inc insider was just granted 12,500 options https://www.conferencecalltranscripts.org/summary/?id=12655593 $ARFXF

User Image cctranscripts Posted - 10/30/23

Promis Neurosciences Inc insider was just granted 2,500 options https://www.conferencecalltranscripts.org/summary/?id=12655589 $ARFXF

User Image cctranscripts Posted - 09/27/23

Registration statement under Securities Act of 1933 https://www.conferencecalltranscripts.org/summary/?id=12571774 $ARFXF

User Image cctranscripts Posted - 09/27/23

Registration statement under Securities Act of 1933 https://www.conferencecalltranscripts.org/summary/?id=12571745 $ARFXF

User Image cctranscripts Posted - 09/26/23

Notice of Effectiveness https://www.conferencecalltranscripts.org/summary/?id=12566458 $ARFXF

User Image cctranscripts Posted - 09/22/23

Registration statement under Securities Act of 1933 https://www.conferencecalltranscripts.org/summary/?id=12561402 $ARFXF

User Image cctranscripts Posted - 09/22/23

Registration statement under Securities Act of 1933 https://www.conferencecalltranscripts.org/summary/?id=12561360 $ARFXF

User Image cctranscripts Posted - 09/22/23

Post-Effective amendments for registration statement https://www.conferencecalltranscripts.org/summary/?id=12561376 $ARFXF

User Image cctranscripts Posted - 09/05/23

Major owner of Promis Neurosciences Inc just declared owning 1,840,489 shares of Promis Neurosc https://www.conferencecalltranscripts.org/summary/?id=12515504 $ARFXF

User Image cctranscripts Posted - 09/05/23

Title just provided an update on share ownership of Promis Neurosciences Inc https://www.conferencecalltranscripts.org/summary/?id=12515280 $ARFXF

User Image cctranscripts Posted - 09/05/23

Jeremy M. Sclar just provided an update on share ownership of Promis Neurosciences Inc https://www.conferencecalltranscripts.org/summary/?id=12514788 $ARFXF

User Image cctranscripts Posted - 08/30/23

Sphera Global Healthcare Management LP just provided an update on share ownership of Promis Neu https://www.conferencecalltranscripts.org/summary/?id=12499763 $ARFXF

User Image cctranscripts Posted - 08/14/23

Promis Neurosciences Inc just filed a prospectus, suggesting it plans to soon issue some securi https://www.conferencecalltranscripts.org/summary/?id=12456663 $ARFXF

User Image cctranscripts Posted - 08/14/23

Promis Neurosciences Announces Second Quarter 2023 Financial Results And Recent Highlights https://www.conferencecalltranscripts.org/summary/?id=12456565 $ARFXF

User Image cctranscripts Posted - 08/14/23

Promis Neurosciences Inc Just Filed Its Quarterly Report: 11.NET LOSS PER SHAR... https://www.conferencecalltranscripts.org/summary/?id=12456557 $ARFXF

User Image Mondoshis13 Posted - 08/03/23

$ARFXF $YELLQ $AMC

User Image ntranllc Posted - 07/18/23

$ARFXF offering immediately

User Image cctranscripts Posted - 07/14/23

Promis Neurosciences Inc just filed a prospectus, suggesting it plans to soon issue some securi https://www.conferencecalltranscripts.org/summary/?id=12363405 $ARFXF

User Image cctranscripts Posted - 07/14/23

Material Modification to Rights of Security https://www.conferencecalltranscripts.org/summary/?id=12363400 $ARFXF